Apatinib treatment efficiently delays biochemical-only recurrent ovarian cancer progression

BACKGROUND: Biochemical recurrence is defined as only rising CA-125 but no radiographic evidence of disease; noteworthily, it generally precedes the onset of clinical evidence. Now treatment strategies of biochemical recurrence ovarian cancer (OC) remain controversial. Apatinib as monotherapy or in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhongyu, Huang, Yake, Long, Ling, Zhou, Li, Huang, Yan, Gan, Lei, Pu, Aimin, Li, Sufen, Xie, Rongkai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274012/
https://www.ncbi.nlm.nih.gov/pubmed/34247630
http://dx.doi.org/10.1186/s13048-021-00843-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274012/
https://www.ncbi.nlm.nih.gov/pubmed/34247630
http://dx.doi.org/10.1186/s13048-021-00843-8

Ejemplares similares